BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Next Generation of MyoScience Inc. Device Receives FDA Clearance for Pain Management


7/10/2012 7:46:05 AM

REDWOOD CITY, Calif., July 10, 2012 (GLOBE NEWSWIRE) -- The newest generation of myoscience's novel device technology has received FDA clearance for the treatment of pain.

myoscience's patented technology precisely delivers cold to targeted nerves. The cold induces a hibernating state resulting in a temporary interruption of nerve signaling to sensory receptors or muscle tissue. The device uses the power of cold to achieve an immediate result with nothing left behind in the patient. The myoscience device received CE approval and a medical device license from Health Canada in 2011.

The hand-held device is intended for use in the physician's office and represents a breakthrough advance in the treatment of pain. The myoscience technology can address multiple indications in a targeted treatment with no systemic side effects or addictive potential.

"FDA clearance for our device in the US provides myoscience with a platform technology on which to grow our company by addressing further indications and an expanding geography," said Clint Carnell, Chief Executive Officer of myoscience.

About myoscience

Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold TherapyTM, the pre-eminent treatment for nerves. Focused Cold Therapy is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions. The myoscience technology has also been cleared in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com.

The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581

Contact:

Clint Carnell650/421-0605



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->